Medline has put forward terms for an absolutely massive IPO, which could see the medical device manufacturing and distribution giant raise as much as $5.37 billion if all goes to plan in the coming weeks.

FDA qualifies 1st AI drug development tool for reading MASH images

New Podnosis episode is live 🎧 The Fierce Healthcare editorial team breaks down the latest federal health policy shifts and what they mean for hospitals, payers and patients.

Stryker, with its eye on tuck-in acquisitions and streamlining its business core, has promoted 27-year veteran Spencer Stiles to president and chief operating officer to help oversee its global business strategy and M&A.

Resmed believes its AI approach to personalizing its connected CPAP machines can lead to more restful nights for people with obstructive sleep apnea.

After more than 20 years, Medtronic claims deep brain stimulation approval for dystonia

The FDA is continuing its push to adopt emerging artificial intelligence tools, this time unveiling an agentic AI program that employees can choose to use in their work.

Boston Scientific has obtained an approval in Europe for the latest addition to its pulsed field ablation portfolio, with the Farapoint focal catheter.

Researchers said they have uncovered a novel sign of chronic stress and its damaging effects on the body by using an artificial intelligence algorithm to analyze common CT scans for what they describe as a “biological barometer.”

There are two kinds of Americans: those who live 12 minutes from an emergency department and those who live 72. Hospital closures, service cuts and fragile finances are stretching rural healthcare to a breaking point https://t.co/bJtbpFKesG

Johnson & Johnson MedTech is expanding its stroke-focused R&D in Ireland, building on previous investments and coming on the heels of a new innovation center that was completed earlier this year in Galway.

Solventum, which spun out of 3M nearly two years ago, will shell out up to $850 million for wound care specialist Acera Surgical in its first major acquisition.

GE HealthCare is raising the curtain on its spearhead into the field of photon-counting CT, the Photonova Spectra, with an announcement that the system has been submitted to the FDA for review.

Promega wins FDA approval as companion diagnostic for Keytruda-Lenvima combo in uterine cancer

Guardant Health is touting the results of a new study showing its Reveal blood test can detect whether chemotherapy is failing months before evidence shows up on regular scans, allowing oncologists to switch treatment sooner.

Inbrain Neuroelectronics signed a pact with Microsoft to use the tech giant’s Azure AI infrastructure to advance technology.

Precision Neuroscience’s brain-computer interface—a wireless device that aims to restore function to people with paralysis—is getting a boost from SCI Ventures.

IceCure's cryoablation treatment may extend survival in some lung cancer patients, study finds

Chronic conditions “are widespread yet remain invisible” with many people living with long-term disorders “masking” their conditions to shield others.

Jupiter Endovascular, which was formed by Neptune Medical a little more than a year ago, shared positive results from the first-in-human trial of its Vertex TFX catheter platform.